Company Overview and News
TORONTO, June 21, 2018 (GLOBE NEWSWIRE) -- Dalradian Resources Inc. (TSX:DNA) (AIM:DALR) (“Dalradian” or the “Company”) and Orion Mine Finance are pleased to announce that the Company and certain affiliates of Orion Mine Finance (collectively, “Orion”) have entered into a definitive arrangement agreement (the “Arrangement Agreement”), whereby Orion will acquire all of the issued and outstanding common shares of the Company (“Dalradian Shares”) by way of a statutory plan of arrangement under the Business Corporations Act (Ontario) (the “Transaction”).
DRLDF BLK DNA.WT.A FPC OKSWF DRRLF OR OSKGF FPRGF BGMZF DALR DNA
VANCOUVER, British Columbia, June 20, 2018 (GLOBE NEWSWIRE) -- Strongbow Exploration Inc. (TSX-V:SBW) (“Strongbow” or the “Company”) reports that, pursuant to the Share Purchase Agreement (“SPA”) announced March 17, 2016, regarding the acquisition of the South Crofty tin project, the Company has issued a total of 8,456,664 common shares (equivalent to C$2,000,000) to Galena Special Situations Master Fund Limited (“Galena”), and Tin Shield Production Inc (“Tin Shield”).
OKSWF OR OSKGF SBWFF
MONTRÉAL, June 18, 2018 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Company” or “Osisko”) (TSX:OR) (NYSE:OR) is pleased to announce that it has entered into a binding term sheet to provide Falco Resources Ltd. (“Falco”) (TSXV:FPC) with a senior secured silver stream credit facility (“Silver Stream”) with reference to up to 100% of the future silver produced from the Horne 5 property (“Horne 5” or the “Project”) located in Rouyn-Noranda, Québec from Falco.
FPC OKSWF OR OR OSKGF BGMZF FPRGF
MONTREAL, June 18, 2018 (GLOBE NEWSWIRE) -- Falco Resources Ltd. (TSXV:FPC) (“Falco” or the “Company”) is pleased to announce a financing transaction with Osisko Gold Royalties Ltd (TSX:OR) (NYSE:OR) (“Osisko”), pursuant to which Osisko has agreed to commit $180 million through a silver stream (the “Silver Stream Transaction”) toward the funding of the development of Falco’s Horne 5 Project (the “Project”).
FPC OKSWF OR OR OSKGF FPRGF
TORONTO, June 18, 2018 (GLOBE NEWSWIRE) -- Victoria Gold Corp. (the “Company” or ‘Victoria) (TSX-V:VIT-V) is pleased to announce the addition of two experienced and respected mining professionals, Sean Roosen and Jacques Perron, to its Board of Directors representing our two new strategic investors, Osisko Royalties and Orion Resource Partners respectively.
OKSWF CG VITFF TC STADF VIT CAGDF TCM TCPTF OR CCJ OSKGF IAG
MONTREAL, June 01, 2018 (GLOBE NEWSWIRE) -- Falco Resources Ltd. (TSX-V:FPC) (“Falco” or the “Company”) is pleased to announce that in connection with the C$10 million loan (“Loan”) provided by Osisko Gold Royalties Ltd (TSX:OR) (“Osisko”) on May 30, 2016, as amended, that both Falco and Osisko have agreed to extend the maturity to December 31st, 2018.
FPC OKSWF OR OR OSKGF FPRGF
MONTREAL, May 15, 2018 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the “Company” or “Osisko Metals”) (TSX-V:OM) (FRANKFURT:OB51) is pleased to announce assay results from 5 shallow drill holes completed between the L-35 and L-36 deposit areas. Drill hole EM-18-PP-050 intersected 3.84% Zn and 0.92% Pb over 9.25 metres. All reported drill holes intersected near-surface mineralization above 60 metre depths, with multiple mineralized intercepts reported in all holes.
OKSWF OR OSKGF
VANCOUVER, B.C., May 14, 2018 (GLOBE NEWSWIRE) -- Strongbow Exploration Inc. (TSX-V:SBW) (“Strongbow” or the “Company”) is pleased to announce its intention to apply for admission of its common shares (the “Common Shares”) to trading on the AIM Market (“AIM”) of the London Stock Exchange (“Admission”). The Company expects that Admission will become effective in June 2018. The Company’s Common Shares will continue to list, in the immediate future, on the TSX-V in Canada.
OKSWF OR LNSTY OSKGF SBWFF
Good morning, ladies and gentlemen, and welcome to the Osisko Gold Royalties Q1 2018 Results Conference Call. [Operator Instructions]. Please note that this call is being recorded today, May 4, 2018 at 10:00 AM Eastern Time. Today on the call we have Mr. Sean Roosen, Chair of the Board of Directors and Chief Executive Officer of Osisko Gold Royalties; and Mr. Bryan Coates, President of Osisko Gold Royalties.
OKSWF OR MAI OSKGF VITFF VGMTD VIT
MONTREAL, May 04, 2018 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (TSX:OR) (NYSE:OR) announces that, at the annual and special meeting of shareholders held on May 3, 2018, each of the 10 nominees listed in the management information circular filed on March 29, 2018 (the “Circular”) with regulatory authorities were elected as directors of the Corporation.
FPC OKSWF OR OR OSKGF BGMZF FPRGF
2018-06-24 - Asif
History and Development Himax Taiwan, its predecessor, was incorporated on June 12, 2001 as a limited liability company under the laws of the ROC. On April 26, 2005, the company established Himax Technologies Limited, an exempted company with limited liability under the Cayman Islands Companies Law, as a holding company to hold the shares of Himax Taiwan in connection with its reorganization and share exchange. On October 14, 2005, Himax Taiwan became its wholly owned subsidiary through a share exchange consummated pursuant to the ROC Business Mergers and Acquisitions Law through which the company acquired all of the issued and outstanding shares of Himax Taiwan, and the company issued ordinary shares to the shareholders of Himax Taiwan. Shareholders of Himax Taiwan received one of its ordinary shares in exchange for one Himax Taiwan common share. The share exchange was unanimously approved by shareholders of Himax Taiwan on June 10, 2005 with no dissenting shareholders and by ...
2018-06-22 - Asif
Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...
2018-06-22 - Asif
Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...
as of ET